Scientist 3, Immunology
Roche
Summary
The Department of Immunology at Genentech is seeking a highly talented, driven and motivated Scientist 3 to investigate novel biological mechanisms and potential therapeutic targets to treat inflammatory diseases. The successful candidate will lead projects that advance our understanding of the cellular and molecular mechanisms of adaptive and innate immunity, with a main emphasis on harnessing immunoregulatory mechanisms for reestablishing immune and tissue homeostasis under inflammatory conditions.
Job description
The Opportunity
The Department of Immunology at Genentech is seeking a highly talented, driven and motivated Scientist 3 to investigate novel biological mechanisms and potential therapeutic targets to treat inflammatory diseases. The successful candidate will lead projects that advance our understanding of the cellular and molecular mechanisms of adaptive and innate immunity, with a main emphasis on harnessing immunoregulatory mechanisms for reestablishing immune and tissue homeostasis under inflammatory conditions.
The candidate will be expected to work independently and collaboratively on pipeline projects and will be responsible for advancing exciting and novel research stage programs into early clinical development, providing both scientific and technical expertise and generating solid proof of concept data. Prior industry experience is required, particularly in target discovery. Excellent communication skills will facilitate fruitful and open collaborations with other labs in immunology, regenerative medicine, human genetics, biomarker discovery and early clinical development. Using state of the art techniques and technologies, the candidate will have the capacity to develop in vitro and in vivo skills to test the involvement of novel pathways and molecules in the pathogenesis of inflammatory diseases and to identify the mechanism of action (MOA) of new targets.
Who You Are
- PhD degree in immunology, molecular biology, biochemistry or a related field with a demonstrated record of professional achievement in the form of high-quality publications.
- Extensive hands-on experience in cellular and molecular immunology techniques including primary cell isolation from tissues, in vitro immunological assays, multi-dimensional flow cytometry and in vivo animal models.
- Independently designing, executing and interpreting experiments.
- Have excellent communication skills and willingness to work in a collaborative environment and core lab.
- Can present research at intra- and inter-departmental meetings.
Preferred
- A strong background in adaptive and innate immunity is highly desirable.
- Experience with state-of-the-art precision genome editing technologies and their application for cell engineering is of interest.
- Experience with analysis of data from genomic sequencing, scRNA-seq, TCR-seq, CITE-seq or spatial transcriptomics is a plus.
- Experience with in vivo immunological experimental techniques
- Experience in target discovery within industry research setting
Requirements
- PhD degree in immunology, molecular biology, biochemistry or a related field
- Demonstrated record of professional achievement in the form of high-quality publications
- Extensive hands-on experience in cellular and molecular immunology techniques
- Primary cell isolation from tissues
- In vitro immunological assays
- Multi-dimensional flow cytometry
- In vivo animal models
- Independently designing, executing and interpreting experiments
- Excellent communication skills
- Willingness to work in a collaborative environment and core lab
- Can present research at intra- and inter-departmental meetings
- Prior industry experience, particularly in target discovery
Benefits
- Relocation assistance
- Annual bonus
Company overview
Roche is a Swiss multinational healthcare company and a global pioneer in pharmaceuticals and diagnostics, founded in 1896 and headquartered in Basel, Switzerland. As the world's largest biotech company and the fifth-largest pharmaceutical company by revenue, Roche operates through two primary divisions: Pharmaceuticals and Diagnostics. The company is renowned for its leadership in personalized healthcare, combining strengths in both drug development and diagnostic testing to deliver tailored treatments for patients. Roche maintains a strong focus on oncology, immunology, infectious diseases, ophthalmology, and central nervous system disorders, with a portfolio that includes over 30 medicines on the World Health Organization's Model Lists of Essential Medicines. The company owns significant subsidiaries including Genentech, Chugai Pharmaceuticals, Ventana Medical Systems, and Foundation Medicine. With approximately 103,000 employees worldwide and operations in over 100 countries, Roche has established itself as a leader in cancer treatments globally while maintaining a robust pipeline of innovative therapies and diagnostic solutions. The company's commitment to sustainability has been recognized through ten consecutive years as Group Leader in the Dow Jones Sustainability Indices within the Pharmaceuticals, Biotechnology & Life Sciences Industry.